Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
The emerging role of ketogenic diets in cancer treatment.

Current opinion in clinical nutrition and metabolic care

Klement RJ.
PMID: 30531479
Curr Opin Clin Nutr Metab Care. 2019 Mar;22(2):129-134. doi: 10.1097/MCO.0000000000000540.

PURPOSE OF REVIEW: Altered glucose metabolism in cancer cells is an almost ubiquitous observation, yet hardly exploited therapeutically. However, ketogenic diets have gained growing attention in recent years as a nontoxic broad-spectrum approach to target this major metabolic difference...

Cite
Klement RJ. The emerging role of ketogenic diets in cancer treatment. Curr Opin Clin Nutr Metab Care. 2019;22(2):129-134doi: 10.1097/MCO.0000000000000540.
Klement, R. J. (2019). The emerging role of ketogenic diets in cancer treatment. Current opinion in clinical nutrition and metabolic care, 22(2), 129-134. https://doi.org/10.1097/MCO.0000000000000540
Klement, Rainer Johannes. "The emerging role of ketogenic diets in cancer treatment." Current opinion in clinical nutrition and metabolic care vol. 22,2 (2019): 129-134. doi: https://doi.org/10.1097/MCO.0000000000000540
Klement RJ. The emerging role of ketogenic diets in cancer treatment. Curr Opin Clin Nutr Metab Care. 2019 Mar;22(2):129-134. doi: 10.1097/MCO.0000000000000540. PMID: 30531479.
Copy Download .nbib Format: NLM
Ketogenic diet in the treatment of cancer - Where do we stand?.

Molecular metabolism

Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B.
PMID: 31399389
Mol Metab. 2020 Mar;33:102-121. doi: 10.1016/j.molmet.2019.06.026. Epub 2019 Jul 27.

BACKGROUND: Cancer is one of the greatest public health challenges worldwide, and we still lack complementary approaches to significantly enhance the efficacy of standard anticancer therapies. The ketogenic diet, a high-fat, low-carbohydrate diet with adequate amounts of protein, appears...

Cite
Weber DD, Aminzadeh-Gohari S, Tulipan J, et al. Ketogenic diet in the treatment of cancer - Where do we stand?. Mol Metab. 2019;33:102-121doi: 10.1016/j.molmet.2019.06.026.
Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020). Ketogenic diet in the treatment of cancer - Where do we stand?. Molecular metabolism, 33102-121. https://doi.org/10.1016/j.molmet.2019.06.026
Weber, Daniela D, et al. "Ketogenic diet in the treatment of cancer - Where do we stand?." Molecular metabolism vol. 33 (2020): 102-121. doi: https://doi.org/10.1016/j.molmet.2019.06.026
Weber DD, Aminzadeh-Gohari S, Tulipan J, Catalano L, Feichtinger RG, Kofler B. Ketogenic diet in the treatment of cancer - Where do we stand?. Mol Metab. 2020 Mar;33:102-121. doi: 10.1016/j.molmet.2019.06.026. Epub 2019 Jul 27. PMID: 31399389; PMCID: PMC7056920.
Copy Download .nbib Format: NLM
Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation.

Epilepsia

Kossoff EH, Shields WD.
PMID: 25284035
Epilepsia. 2014 Sep;55:29-33. doi: 10.1111/epi.12546.

Individuals with Lennox-Gastaut syndrome (LGS) often do not respond to or become resistant to pharmacologic treatments. Ketogenic diets (KDs) and vagus nerve stimulation (VNS) are nonpharmacologic treatment options for these intractable patients. The classic KD, a high-fat, low-carbohydrate diet...

Cite
Kossoff EH, Shields WD. Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation. Epilepsia. 2014;55:29-33doi: 10.1111/epi.12546.
Kossoff, E. H., & Shields, W. D. (2014). Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation. Epilepsia, 5529-33. https://doi.org/10.1111/epi.12546
Kossoff, Eric H W, and Shields, W Donald. "Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation." Epilepsia vol. 55 (2014): 29-33. doi: https://doi.org/10.1111/epi.12546
Kossoff EH, Shields WD. Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation. Epilepsia. 2014 Sep;55:29-33. doi: 10.1111/epi.12546. PMID: 25284035.
Copy Download .nbib Format: NLM
Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis.

Epilepsia

Lyons L, Schoeler NE, Langan D, Cross JH.
PMID: 32452537
Epilepsia. 2020 Jun;61(6):1261-1281. doi: 10.1111/epi.16543. Epub 2020 May 26.

OBJECTIVE: Ketogenic diet therapy (KDT) is a group of high-fat, low-carbohydrate diets used as an effective treatment option for children and adults with drug-resistant epilepsy. There is limited research on the efficacy of KDT in infants, where there is...

Cite
Lyons L, Schoeler NE, Langan D, et al. Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis. Epilepsia. 2020;61(6):1261-1281doi: 10.1111/epi.16543.
Lyons, L., Schoeler, N. E., Langan, D., & Cross, J. H. (2020). Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis. Epilepsia, 61(6), 1261-1281. https://doi.org/10.1111/epi.16543
Lyons, Laura, et al. "Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis." Epilepsia vol. 61,6 (2020): 1261-1281. doi: https://doi.org/10.1111/epi.16543
Lyons L, Schoeler NE, Langan D, Cross JH. Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis. Epilepsia. 2020 Jun;61(6):1261-1281. doi: 10.1111/epi.16543. Epub 2020 May 26. PMID: 32452537.
Copy Download .nbib Format: NLM
Reason for optimism: a parent's perspective.

Journal of child neurology

Abrahams J.
PMID: 23653424
J Child Neurol. 2013 Aug;28(8):1052-3. doi: 10.1177/0883073813487602. Epub 2013 May 07.

The ketogenic diet is increasing in popularity worldwide, as evidenced by this symposium. More child neurologists are prescribing it in more countries. However, the diet is still underutilized, only occasionally rising to the level of "last resort" among treatment...

Cite
Abrahams J. Reason for optimism: a parent's perspective. J Child Neurol. 2013;28(8):1052-3doi: 10.1177/0883073813487602.
Abrahams, J. (2013). Reason for optimism: a parent's perspective. Journal of child neurology, 28(8), 1052-3. https://doi.org/10.1177/0883073813487602
Abrahams, Jim. "Reason for optimism: a parent's perspective." Journal of child neurology vol. 28,8 (2013): 1052-3. doi: https://doi.org/10.1177/0883073813487602
Abrahams J. Reason for optimism: a parent's perspective. J Child Neurol. 2013 Aug;28(8):1052-3. doi: 10.1177/0883073813487602. Epub 2013 May 07. PMID: 23653424.
Copy Download .nbib Format: NLM
The ketogenic diet in pharmacoresistant childhood epilepsy.

Expert review of neurotherapeutics

Winesett SP, Bessone SK, Kossoff EH.
PMID: 25994046
Expert Rev Neurother. 2015 Jun;15(6):621-8. doi: 10.1586/14737175.2015.1044982. Epub 2015 May 20.

Available pharmacologic treatments for seizures are limited in their efficacy. For a patient with seizures, pharmacologic treatment with available anticonvulsant medications leads to seizure control in

Cite
Winesett SP, Bessone SK, Kossoff EH. The ketogenic diet in pharmacoresistant childhood epilepsy. Expert Rev Neurother. 2015;15(6):621-8doi: 10.1586/14737175.2015.1044982.
Winesett, S. P., Bessone, S. K., & Kossoff, E. H. (2015). The ketogenic diet in pharmacoresistant childhood epilepsy. Expert review of neurotherapeutics, 15(6), 621-8. https://doi.org/10.1586/14737175.2015.1044982
Winesett, Steven Parrish, et al. "The ketogenic diet in pharmacoresistant childhood epilepsy." Expert review of neurotherapeutics vol. 15,6 (2015): 621-8. doi: https://doi.org/10.1586/14737175.2015.1044982
Winesett SP, Bessone SK, Kossoff EH. The ketogenic diet in pharmacoresistant childhood epilepsy. Expert Rev Neurother. 2015 Jun;15(6):621-8. doi: 10.1586/14737175.2015.1044982. Epub 2015 May 20. PMID: 25994046.
Copy Download .nbib Format: NLM
Ketogenic diet.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Dhamija R, Eckert S, Wirrell E.
PMID: 23419562
Can J Neurol Sci. 2013 Mar;40(2):158-67. doi: 10.1017/s0317167100013676.

About one third of patients with epilepsy are pharmacoresistent. For a subgroup of this population, the ketogenic diet can be highly efficacious and should be considered early. This review discusses the different types of ketogenic diet, proposed mechanism of...

Cite
Dhamija R, Eckert S, Wirrell E. Ketogenic diet. Can J Neurol Sci. 2013;40(2):158-67doi: 10.1017/s0317167100013676.
Dhamija, R., Eckert, S., & Wirrell, E. (2013). Ketogenic diet. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 40(2), 158-67. https://doi.org/10.1017/s0317167100013676
Dhamija, Radhika, et al. "Ketogenic diet." The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques vol. 40,2 (2013): 158-67. doi: https://doi.org/10.1017/s0317167100013676
Dhamija R, Eckert S, Wirrell E. Ketogenic diet. Can J Neurol Sci. 2013 Mar;40(2):158-67. doi: 10.1017/s0317167100013676. PMID: 23419562.
Copy Download .nbib Format: NLM
Ketogenic diet, a potentially valuable therapeutic option for the management of refractory epilepsy in classical neonatal nonketotic hyperglycinemia: a case report.

European journal of clinical nutrition

Kava MP, Robertson A, Greed L, Balasubramaniam S.
PMID: 30108280
Eur J Clin Nutr. 2019 Jun;73(6):961-965. doi: 10.1038/s41430-018-0286-8. Epub 2018 Aug 14.

Nonketotic hyperglycinemia (NKH) is a devastating inborn error of glycine metabolism caused by deficient activity of the glycine cleavage enzyme. Classically, patients present with lethargy, hypotonia, myoclonic jerks, transient respiratory depression in the first week of life and often...

Cite
Kava MP, Robertson A, Greed L, et al. Ketogenic diet, a potentially valuable therapeutic option for the management of refractory epilepsy in classical neonatal nonketotic hyperglycinemia: a case report. Eur J Clin Nutr. 2018;73(6):961-965doi: 10.1038/s41430-018-0286-8.
Kava, M. P., Robertson, A., Greed, L., & Balasubramaniam, S. (2019). Ketogenic diet, a potentially valuable therapeutic option for the management of refractory epilepsy in classical neonatal nonketotic hyperglycinemia: a case report. European journal of clinical nutrition, 73(6), 961-965. https://doi.org/10.1038/s41430-018-0286-8
Kava, Maina P, et al. "Ketogenic diet, a potentially valuable therapeutic option for the management of refractory epilepsy in classical neonatal nonketotic hyperglycinemia: a case report." European journal of clinical nutrition vol. 73,6 (2019): 961-965. doi: https://doi.org/10.1038/s41430-018-0286-8
Kava MP, Robertson A, Greed L, Balasubramaniam S. Ketogenic diet, a potentially valuable therapeutic option for the management of refractory epilepsy in classical neonatal nonketotic hyperglycinemia: a case report. Eur J Clin Nutr. 2019 Jun;73(6):961-965. doi: 10.1038/s41430-018-0286-8. Epub 2018 Aug 14. PMID: 30108280.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries